Literature DB >> 402944

Soluble and microsomal forms of NADH-cytochrome beta 5 reductase from human placenta. Similarity with NADH-methemoglobin reductase from human erythrocytes.

A Leroux, L Torlinski, J C Kaplan.   

Abstract

In congenital methemoglobinemia associated with mental retardation a generalized deficiency of NADH-cytochrome beta 5 reductase (NADH : ferricytochrome beta 5 oxidoreductase, EC 1.6.2.2) has been found in soluble extracts of red blood cells, as well as in deoxycholate-treated extracts of leukocytes, muscle, liver and fibroblasts (Leroux et al. (1975) Nature 258, 619-620). In the present study the relationship between the microsomal (I) and the soluble (II) NADH-cytochrome beta 5 reductase was investigated, using human placenta as a source of enzyme. Both forms were compared to the human red-cell soluble NADH-methemoglobin reductase (III) and NADH-cytochrome beta 5 reductase (IV). The four entities exhibited great immunological similarities. It is concluded that the three soluble enzymes (II, III and IV) are identical. The detergent-solubilized microsomal NADH-cytochrome beta 5 reductase (I) is immunologically very similar to the soluble enzymes, but presents distinct features possibly due to the presence of a hydrophobic part.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 402944     DOI: 10.1016/0005-2744(77)90136-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

Review 1.  Advances in hereditary red cell enzyme anomalies.

Authors:  A Kahn; J C Kaplan; J C Dreyfus
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  NADH-methemoglobin reductase activity in the erythrocytes of newborn and adult mammals.

Authors:  S C Lo; N S Agar
Journal:  Experientia       Date:  1986-12-01

3.  Quantitative variations of red-cell cytochrome b5 reductase (NADH-methemoglobin-reductase) in the Algerian population: evidence for defective alleles.

Authors:  A Reghis; M Benabadji; P Tchen; J C Kaplan
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

4.  Transcriptional and translational mechanisms of cytochrome b5 reductase isoenzyme generation in humans.

Authors:  A Leroux; L Mota Vieira; A Kahn
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

5.  Membrane-bound cytochrome b5 reductase (methemoglobin reductase) in human erythrocytes. Study in normal and methemoglobinemic subjects.

Authors:  D Choury; A Leroux; J C Kaplan
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

6.  Interaction between cytochrome b5 and hemoglobin: involvement of beta 66 (E10) and beta 95 (FG2) lysyl residues of hemoglobin.

Authors:  G Gacon; D Lostanlen; D Labie; J C Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

7.  Assignment of NADH-cytochrome b5 reductase (DIA1 locus) to human chromosome 22.

Authors:  C Junien; M Vibert; D Weil; N Van-Cong; J C Kaplan
Journal:  Hum Genet       Date:  1978-06-27       Impact factor: 4.132

8.  NADH cytochrome b5 reductase activity in lymphoid cell lines. Expression of the defect in epstein Barr virus transformed lymphoblastoid cell lines from patients with recessive congenital methemoglobinemia.

Authors:  D Lostanlen; G Lenoir; J C Kaplan
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

9.  Alteration of NADH-diaphorase and cytochrome b5 reductase activities of erythrocytes, platelets, and leucocytes in hereditary methaemoglobinaemia with and without mental retardation.

Authors:  M Takeshita; T Matsuki; K Tanishima; T Yubisui; Y Yoneyama; K Kurata; N Hara; T Igarashi
Journal:  J Med Genet       Date:  1982-06       Impact factor: 6.318

10.  Development and validation of a spectrophotometric assay for measuring the activity of NADH: cytochrome b5 reductase in human tumour cells.

Authors:  H M Barham; R Inglis; E C Chinje; I J Stratford
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.